Skip to content

Webinar Ticagrelor removal by CytoSorb / Budget impact analysis of CytoSorb Therapy in emergency open-heart surgery patients receiving Ticagrelor (Brilliere)

Ticagrelor removal by CytoSorb in patients with acute coronary syndrome – clinical benefits and scientific results.
Priv. Doz. Dr. med. Stephan Geidel
Chief Senior Physician Cardiac Surgery – Asklepios Klinik St. Georg, Hamburg

Budget impact analysis of CytoSorb therapy in emergency open-heart surgery patients receiving Ticagrelor (Brillique).
Daniel Adam Blanco
Manager Health Economics – CytoSorbents Europe GmbH, Berlin

Play Video

Share

|

Webinar Ticagrelor removal by CytoSorb / Budget impact analysis of CytoSorb Therapy in emergency open-heart surgery patients receiving Ticagrelor (Brilliere)

Play Video

Share

|

Ticagrelor removal by CytoSorb in patients with acute coronary syndrome – clinical benefits and scientific results.
Priv. Doz. Dr. med. Stephan Geidel
Chief Senior Physician Cardiac Surgery – Asklepios Klinik St. Georg, Hamburg

Budget impact analysis of CytoSorb therapy in emergency open-heart surgery patients receiving Ticagrelor (Brillique).
Daniel Adam Blanco
Manager Health Economics – CytoSorbents Europe GmbH, Berlin